戻る
AbbVie Inc (ABBV)価格
ABBV 株価推移チャート
ABBV 収入
AbbVie Inc
$214.35
-1.1%
$-2.4
終値： Jan 16, 16:00:00 GMT-5
$214.66
0.14%
$0.31
アフターマーケット：Jan 16, 20:00:00 GMT-5
A-
最終スコア
主要データ
前終値
$216.75
始値
$215.61
当日レンジ
$213.88 - $217.34
52週レンジ
$164.39 - $244.81
取引高
7.8M
平均取引高
5.8M
1株当たり利益(TTM)
1.35
配当利回り
2.83%
時価総額
$379.3B
ABBVとは何ですか？
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 55,000 full-time employees. The company went IPO on 2013-01-02. The company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).